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Summary Spheroids derived from the human colon adenocarcinoma cell line, WiDr, were exposed to
lOpgmlPl Photofrin II and irradiated with light (700nm, 5OmWcm-2). Compared with exponentially
growing monolayer cultures, cells in spheroids of 100, 250 and 500um diameter were respectively 1.8, 2.5 and
22-fold less sensitive. The small resistance of plateau-phase cultures (1.3-fold) was insuflicient to account for
this marked spheroid size-dependent resistance. For monolayer cultures and for spheroids of 100 and 250pm
diameter, the results were the same whether irradiations were carried out pre- or post-trypsinisation. However,
there was a difference for the largest spheroid size: when irradiations were carried out pre-trypsinisation,
spheroids were more resistant than when irradiations were given post-trypsinisation. Drug extraction studies
showed that there was no difference in the average drug uptake between cultures ofexponentially growing or
plateau-phase cells, and lOOpm diameter spheroids while 250 and 500pm diameter spheroids took up
proportionally 0.5 and 0.4 as much drug. Cell contact effects, drug heterogeneity between cells, hypoxia and
problems in drug penetration are suggested as possible reasons for the resistance of large spheroids to
photodynamic treatment.
During the past decade there has been increasing interest in
the potential of photodynamic therapy (PDT) as a new
modality for the treatment of cancer. Although many of the
factors determining response have been investigated, there
are still many areas of the biology of PDT yet to be studied.
The use of multicellular spheroids as a tool for the
investigation of tumour response to other therapies is well
established. They are useful, for example, for assessing the
contribution of hypoxia (Sutherland et al., 1970; West et al.,
1984; West & Sutherland, 1987), diffusion limitations
(Sutherland et al., 1979; Durand, 1981), cell contact effects
(Durand & Sutherland, 1972; West & Stratford, 1987), and
repair processes (Durand & Sutherland, 1972; West et al.,
1984) in the response of cells to a particular treatment.
The resistance of spheroids to photodynamic treatment
has been documented previously (Christensen et al., 1984).
However, to date, there has been no systematic study of the
effect of spheroid size on the development of this resistance.
In addition, there have been conflicting reports of the effect
of cell growth phase on sensitivity to photodynamic
treatment. Christensen et al. (1984) reported that log- and
plateau-phase NHIK 3025 cells were equally sensitive to
haematoporphyrin derivative (HPD) plus light, while Ben-
Hur et al. (1987) showed that V79 cells in the plateau-phase
of growth were more sensitive than exponentially growing
cells to photosensitisation with chloroaluminium
phthalocyanine.
The following work describes a study of the effect of
spheroid size on photosensitisation by Photofrin II. In
addition, the role of the growth phase of cells during drug
exposure has been investigated. The end-point used was
clonogenic cell survival.
Materials and methods
Monolayer cultures
The human colon adenocarcinoma cell line, WiDr, was
obtained from the American Type Culture Collection
(Rockville, MD, USA) at passage 24 from the original
tumour. The cells were maintained in exponential growth in
Eagle's basal medium (BME, Gibco, Paisley, Scotland) plus
10% fetal calf serum (FCS, Gibco), supplemented with
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penicillin (Gibco, lOOlUml-1) and streptomycin (Gibco,
O.1mgml-1). Cultures were incubated in a humidified 5%
Co2 atmosphere and subcultured weekly using 0.01%
trypsin (180IUmg-1, Worthington Diagnostics Ltd,
Freehold, NJ, USA) in 0.02% ethylenediamine tetra-acetic
acid (EDTA, BDH Chemicals Ltd, Poole, England) made
up in phosphate buffered saline (PBS, pH 7.3). Under these
conditions the cells grew with a doubling time of 0.8 days
and a plating efficiency of around 90%. Stocks of cells were
stored frozen and experiments were carried out on cell
passages 28-44 from the original tumour. Cultures were
tested routinely for Mycoplasma.
Spheroid cultures
Multicellular spheroids were initiated by inoculating 5 x 105
cells in 10ml growth medium on to 100mm Petri dishes
which had been underlayed previously with 1% agar (Noble;
Difco, Detroit, MC, USA) in BME without serum. After 5
days' incubation, spheroids were filtered through 95 and
100pm nylon screens to obtain a homogeneous population
and approximately 1,000 were placed in 95mm diameter
spinner flasks (Techne) containing 250ml growth medium.
Flasks were gassed with an air plus 5% CO2 gas mixture
and placed on magnetic stirrers set at 60r.p.m. in a 37°C
warm room. The medium was replaced thrice-weekly and
when spheroids had reached approximately 300,pm in
diameter the number of spheroids per flask was reduced to
500 and the stir rate increased to 80r.p.m. Spheroids were
dissociated to single cells using a 15min exposure to 0.05%
trypsin in EDTA.
Drug exposure
Photofrin II (batch number PC238C), 2.5mgmlsaline 1, was
a gift from Photomedica Inc. (New York, USA). On arrival
the drug was thawed and aliquoted into small quantities
which were stored frozen at -20°C and thawed immediately
before use. Exponentially growing (days 4-7 cultures) and
unfed plateau-phase (days 12-13) monolayer cultures were
exposed to 10pgmlPl drug in BME plus 10% FCS. After
24h the drug containing medium was removed, the cells
washed and fresh BMEplus 10% FCS added for a further 1 h.
Thecellsweretrypsinised,resuspendedat3-5 x 105cellsml1 in
Hepes-buffered BME plus 10% FCS at room temperature,
and 1 ml aliquots were placed into 35mm Petri dishes.
Spheroids were selected for the appropriate size and the size
distribution estimated by measuring 30. Then size-selected
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spheroid cultures were exposed to drug, 10pgml - in 70ml
growth medium, in small Techne flasks (65 mm diameter).
After 24h the spheroids were harvested by sedimentation,
rinsed in BME plus 10% FCS, placed in fresh growth
medium in a Petri dish and incubated at 37°C. After 1 h,
one-half of the spheroids were trypsinised and then either
intact or disaggregated spheroids were placed in 1 ml Hepes
buffered BME plus 10% FCS in 35mm Petri dishes.
Light irradiation
The light source used has been described in detail elsewhere
(Moore et al., 1986). Briefly, light irradiations were carried
out using 12V, 1OOW quartz tungsten halogen lamps
('Xenophot HLX', Wotan, London) with a KG1 infra-red
filter (Schott, Mainz, FR Germany). This set-up produced
light within the wavelength range 300-1,100nm, with peak
spectral irradiations at 700nm. A circular light beam of
50mm diameter uniform to 10% across the beam was
produced with a power density at the working surface of
50mWcm 2. Single cell suspensions, 1 ml at 3-5
x 105cellsml-1, Hepes buffered BME plus 10% FCS,
were irradiated at room temperature in 35mm Petri dishes
with the lids removed. For some experiments exponentially
growing monolayers were irradiated before trypsinisation.
Cells were seeded on to 35mm dishes and exposed to drug
and washed as described above. At 1.5h post-wash, the cells
were irradiated and immediately trypsinised. Likewise,
spheroids irradiated pre-trypsin were irradiated in 35mm
dishes in 1 ml Hepes buffered growth medium 1.5 h after
removal of the drug, and then trypsinised. The longest
irradiation time was 1lmin 40s and during this time the
maximum recorded temperature rise was from 20 to 24°C.
Cell survival
Following illumination, the cells were counted, serially
diluted and appropriate numbers plated in triplicate in BME
plus 10% FCS on to 60mm Petri dishes. The dishes were
incubated at 37°C in an air plus 5% CO2 atmosphere. After
21 days colonies were stained with methylene blue and
counted. Curves were fitted to all data using a single-hit,
multi-target type equation (e.g. Gilbert, 1969). Use of such
equations, derived initially to described survival after
exposure to sparsely ionising radiation, gave adequate
empiric fits to the data. However, the interpretation of the
curve shapes may well differ for the two modalities. From
the fitted curves, values were obtained for the parameter Do (the reciprocal of the slope of the final exponential portion
of the curve). In order to test for differences between curves,
analysis of variance was carried out. x2 values were obtained
for sets of curves fitted independently or pooled. An f test
was then used to examine for significant differences between
the x2.
Drug uptake
The method used for measuring drug uptake by cells has
been described elsewhere (Pantelides et al., 1989). Monolayer
cultures and spheroids were exposed to drug, washed and
trypsinised as described above. After washing in PBS,
106cells were resuspended in 1 ml 0.1M Hepes and 10mM
cetryltrimethylammonium bromide at pH 7 and vortexed for
30s. Samples were protected from light and stored at
-20°C. On the day of analysis, samples were thawed and
5ml of a 1:4 solution of ethyl acetate:glacial acetic acid was
added, followed by 4ml 1MHCl. Two layers resulted and
the volume of the lower, containing the extracted porphyrins
in HCI, was recorded. Fluorescence was measured at room
temperature, using a spectrofluorophotometer (Shimatzu)
before and after the sample had been incubated in a water
bath at 90°C for 10min (to monomerise aggregated drug).
Excitation was at 404nm with fluorescence emission
measured at 594nm. A standard curve was produced by
adding known amounts of drug to [MmHCl. This was linear
up to at least 0.4pgml -1. There was no fluorescence
quenching by the cells up to at least a cell density of
2 x 106cellsml-1. Fluorescence measurements were made on
cells that had not been exposed to Photofrin II, and the
values were found to be negligible. All measurements were
carried out in triplicate on four separate occasions and the
mean (of the means)+standard error of the mean (s.e.m.)
was calculated.
Results
Figure 1 illustrates the sensitivity of exponentially growing
WiDr cells that had been exposed to 10 gml-I Photofrin II
for 24h, washed for 1 h in BME plus 10% FCS and
irradiated with light. Light alone, up to 103Jcm-2 has been
shown previously to be non-toxic to the cells (West &
Moore, 1988) and so light-only controls were not carried
out routinely. Drug-only exposed cells formed the control
for all experiments and plating efficiencies did not fall below
the range of values expected for cells without the drug. It
has been shown already that, under the experimental
conditions employed, only Photofrin II levels greater than
150pgml-1 were toxic to WiDr cells (West & Moore,
1988). The sensitivity of the cells to Photofrin II plus light
was the same whether irradiations were carried out before or
after trypsinisation (Figure 1). A single experiment is shown
in which cells were irradiated pre- and post-trypsinisation on
the same day. There was no significant difference in the
survival curves shown (P=0.735). This suggests that (1)
treatment of WiDr cells with trypsin does not make them
more fragile and so more sensitive to subsequent light
treatment and (2) the washing procedure was sufficient to
remove all loosely bound drug from the cells.
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Figure 1 The sensitivity of exponentially growing WiDr cells to
a 24h exposure to 10 gmml-I Photofrin II and a 1 h wash (both in BME+ 10% FCS), trypsinisation and irradiation with light. A
single experiment is shown in which cells were irradiated both
before (open circles) and following (filled circles) trypsinisation
to a single cell suspension. Individual data points are shown
which are the average of three replicate plates. Different symbols
represent independent experiments.
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Unfed plateau-phase cultures were more resistant to
Photofrin II photosensitisation (by a factor of 1.3; taken
from the ratio of the Dos) than exponentially growing cells
(Figure 2). Two experiments are shown in which log- and
plateau-phase cells were compared on the same day. Analysis
of the curves fitted to both sets of data showed them to be
significantly different (P<0.01).
Cells in small spheroids, approximately 100 and 250pm in
diameter, were 1.8- and 2.5-fold more resistant than
exponentially growing monolayers (Figure 3). For both
spheroid sizes, the sensitivity to photodynamic treatment
was the same whether irradiations were carried out pre- or
post-trypsinisation. Large spheroids, 500 pm in diameter,
showed markedly greater resistance to photodynamic
treatment (22-fold compared with exponentially growing
cells). For these spheroids there was a difference between the
curves for irradiating pre- and post-trypsinisation (Figure
3c). Back-extrapolation of the higher-dose portion of the
curve for 500 pm spheroids irradiated intact, suggested a
resistant sub-population of about 40%.
Drug uptake studies were carried out (Table I). There was
no statistical difference in the average amount of drug
uptake by cells from exponentially growing and plateau-
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phase cultures and 100 pm diameter spheroids. Cells from
larger spheroids, 250 and 500 pm in diameter, took up
proportionally 0.5 and 0.4 as much drug respectively.
Discussion
The relative resistance of plateau-phase cultures to photo-
dynamic treatment is not in accordance with observations
published previously by others. It has been reported that log-
and plateau-phase NHIK cells are equally sensitive to HPD
plus light (Christensen et al., 1984) and that plateau-phase
V79 cells are more sensitive than those in log-phase to
chloroaluminium phthalocyanine (Ben-Hur et al., 1987).
Although these studies involved different photosensitisers,
the results may parallel the situation seen for sensitivity to
sparsely ionising radiation where some cell lines are equally
sensitive across the growth phases, others are more sensitive
in plateau-phase and others more sensitive in log-phase
(Hahn & Little, 1972). Interestingly, cultures of WiDr cells
are more sensitive to sparsely ionising radiation when
irradiated in the plateau-phase of growth (West et al., 1988).
The resistance of plateau-phase WiDr cells to photodynamic
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Figure 2 The sensitivity of plateau-phase cells (filled symbols)
to Photofrin II plus light (conditions as in Figure 1). Individual
data points from four separate experiments. For two experi-
ments, exponentially growing (open symbols) and plateau-phase
cells were investigated on the same day.
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Figure 3 The sensitivity of 100 (a), 250 (b) and 500 (c) pm
diameter spheroids to Photofrin II plus light. Spheroids were
irradiated both pre- (filled symbols) and post- (open symbols)
trypsinisation. Broken lines in a and b indicate response of
exponentially growing monolayer. The curves are compared in d.
Table I A comparison, for different WiDr cultures, of the number of cells per spheroid, the median
cell volume, the drug uptake following exposure to 10jgml-I Photofrin II and the slope of the
survival curve (D.) after subsequent irradiation with light
Median Drug uptake D b
Culture Cells per spheroid cell volume (Um3) (ng 106 cells 1) (Jcm 2)
Log-phase cells - 2,140+ 96 297+34 0.17+0.02
Plateau-phase cells - 1,807+ 93 310+26 0.22+0.03
100pm spheroids 8.3 +4.2 x 102 1,967+237 261 + 8 0.30+0.04
250pm spheroids 5.8+ 1.3 x 103 1,943+ 92 issa 0.42+0.03
500pm spheroids 3.5+0.56x 104 1,818+ 88 115+18 3.80+0.31c
Mean+s.e.m. for four independent experiments. aMean oftwo independent measurements; bObtained
by computer-fitting of survival curves; 'Spheroids irradiated post-trypsinisation.SPHEROID RESISTANCE TO PDT 513
treatment may be related to a cell cycle effect. There is an
increase in the proportion of G1-like cells with increasing
WiDr culture age from 68 (day 6 cultures) to 78% (day 12)
(15% increase (West et al., 1988)). It has been shown that,
for some cell lines, G1 cells are the most resistant of cells in
the cell cycle to photodynamic treatment (Christensen et al.,
1981). It is possible that WiDr cells show a variable cell cycle
response with G1 resistance and that the increase in
proportion of G1 cells in plateau-phase cultures accounts for
resistance to PDT. This is supported by the similarity in
drug uptake between exponentially growing and plateau-
phase cells (Table I). In contrast to the results of Christensen
et al. (1981), Gomer & Smith (1980) showed no cell cycle
response, further supporting the notion of cell line
dependent, growth phase related differences.
Although the presence of oxygen is essential for
photosensitiser-induced light cytotoxicity (Moan & Sommer,
1985), the size-dependent spheroid resistance seen here may
not be related to the presence of hypoxia. For small
spheroids there was no difference in photodynamic
sensitivity when light irradiations were carried out both
before and after trypsinisation to single cell suspensions.
This indicates that there was no induced hypoxia as a result
of static culture conditions (using static culture conditions
for irradiation with sparsely ionising radiation can lead to an
increase in the level ofhypoxia in spheroids (Durand, 1980)).
Secondly, irradiations were carried out in fresh medium and
at room temperature, both of which are known to lead to
spheroid reoxygenation (e.g. Franko & Koch, 1983). Thirdly,
WiDr spheroids, up to 500,pm in diameter, do not contain
central necrosis or radiobiological hypoxia, i.e. there is no
hypoxic fraction on the radiation survival curve for 500,pm spheroids (West, unpublished data). The induction of a
hypoxic region in the larger spheroids during light exposure
cannot be totally ruled out because of the difference in
sensitivity for spheroids irradiated pre- and post-
trypsinisation. However, this may be due also to inefficient
light penetration through spheroids. The depth of
penetration of light in tissue has been described as being 200,um at 400 nm and 1mm at 700 nm (Eichler et al., 1977). A broad spectrum light source was used (West & Moore,
1988) and absorption by Photofrin II of shorter, less
penetrating wavelengths (350-550nm) dominates its cyto- toxic effect (West & Moore, 1989).
The question of interest is what causes the marked
spheroid size dependent resistance? The small resistance of
100pm diameter spheroids may be related to a cell contact
effect and there is some evidence that this can occur in
monolayer cultures (Christensen & Moan, 1980). The
resistance of plateau-phase cells and reduced uptake may be
involved also. However, although these may account for the
resistance of the smaller spheroid sizes (100, 250pm), because of the magnitude of the effect, other factors must be
involved in the resistance of large spheroids.
There is some indication that heterogeneity ofdrug uptake
may be important. The majority of in vitro photodynamic
survival curves have broad and clearly defined shoulders
similar to that illustrated in Figure 1 (see also Gomer &
Smith, 1980). Spheroids, 100 and 250pm in diameter, gave similar shaped curves while the curve for 500pm diameter
spheroids was a straight line (Figure 3d). It is interesting to
compare this spheroid survival curve with that for
exponentially growing cells exposed to lpgml - drug (Figure 4). Comparison of drug uptake showed that cells
exposed to 10-fold less drug accumulated 10-fold less drug (West, unpublished data) and were 10-fold less sensitive
(taken from a ratio of Dos (West & Moore, 1988)) Spheroids of 500pm diameter took up 3-fold less drug but
were 22-fold less sensitive than exponentially growing monolayers. The straight line of the 500pm spheroid 'curve'
and the shallower slope than would be expected on the basis
of reduced average drug uptake suggest an increase in
heterogeneity. It is possible that there is a wide spectrum of
intracellular drug levels following the exposure of large
spheroids to Photofrin II. A compilation of a number of
PDT survival curves for different drug-exposed cell
populations would produce a survival curve with a shallower
slope than each of the composite curves (see Dutreix et al.,
1988) and a curve without a shoulder.
A drug penetration problem is the obvious explanation
and our initial expectation was of a gradient in drug
concentration from the peripheral to the central region. This
has been demonstrated in spheroids exposed to the chemo-
therapeutic agent adriamycin (Sutherland et al., 1979).
However, preliminary studies of fluorescence micrographs of
centrally cut frozen sections of Photofrin TI-exposed
spheroids suggest good overall penetration but a patchy
distribution between cells with some fluorescing brightly and
others dimly regardless of position across the spheroid
(West, unpublished data). In addition, there is no tail to the
survival curve for spheroids irradiated post-trypsinisation
which would be seen if there was a drug-free sub-population
of cells.
If drug penetration is not thought to be the cause of
heterogeneity of drug uptake within spheroids, what is? It
could be related to a cell contact effect. The degree of cell
coupling has been shown to decrease as a function of
spheroid age and size (Dertinger et al., 1982). Alternatively,
or in addition, decreased drug uptake in some cells of
spheroids may be related to membrane changes that might
occur with increasing spheroid size. Serum lipoproteins have
a high affinity for haematoporphyrins and drug uptake may
be via receptor-mediated endocytosis of complexes of
porphyrin with low density lipoprotein (LDL; see Barel et al.
(1986) for discussion). There may be a decrease in the
number of LDL receptors in some cells when grown in close
contact, leading to an increase in the heterogeneity of drug
intake.
In conclusion a marked spheroid size dependent resistance
to photodynamic treatment has been demonstrated. This
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Figure 4 A comparison of the survival curves for exponentially
growing WiDr cells exposed to 10 (from Figure 1) and 1(from
West & Moore, 1988) pgml - and 500pm diameter spheroids
(from Figure 3c) exposed to l0pgml- Photofrin IIfollowed by
irradiation with light.514 C.M.L. WEST
resistance cannot be explained simply in terms of hypoxia,
reduced drug uptake or the limited penetration of Photofrin
II into spheroids. There is evidence to suggest that hetero-
geneity of intracellular drug levels between cells is important.
This may be mediated via changes in the degree of cell
contact between cells or in the membrane composition of
cells when grown as three-dimensional multicellular
spheroids.
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